Prostate cancer patients have to wait many years to get access to new cancer medicines compared to other countries such as the US. This is resulting in poorer quality of life and death for Australians, according to Australian Advanced Prostate Cancer Support Group committee member Paul Hobson. Hobson cites the example of two new anti-androgen
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.